First Generation Capital Inc. Enters Into Agreement to Purchase Common Shares of Acerus Pharmaceuticals Corporation

/EINPresswire.com/ -- TORONTO, ONTARIO -- (Marketwired) -- 05/13/16 -- Mr. Ian Ihnatowycz announced that effective May 13, 2016, First Generation Capital Inc. entered into an agreement with West Face Long Term Opportunities Global Master L.P. and K2 Principal Fund L.P. pursuant to which First Generation agreed to purchase (the "Transaction") an aggregate of 51,437,691 common shares of Acerus Pharmaceuticals Corporation ("Acerus") for an aggregate price of $10,246,387.90 or $0.1992 per share.

Immediately prior to the Transaction, First Generation owned 51,081,093 common shares of Acerus, or approximately 23.97% of the outstanding common shares. After closing of the Transaction, First Generation will own 102,518,784 common shares or approximately 48.1% of the outstanding common shares of Acerus.

The Transaction is being conducted privately in accordance with the "private agreement" exemption contained in section 4.2 of National Instrument 62-104.

The common shares are being acquired and will be held for investment purposes. Depending upon the circumstances, Mr. Ihnatowycz and/or First Generation Capital Inc. may, from time to time, acquire additional securities or related financial instruments of Acerus or dispose of all or a portion of the securities or related financial instruments of Acerus previously acquired.

Additional information is provided in the early warning report filed on www.sedar.com.

For further information or a copy of the early warning report please contact:

First Generation Capital Inc.

40 King Street West, Suite 3515

Toronto, ON M5H 3Y2

Attention: Ian Ihnatowycz, President and CEO

Telephone: (416) 304-9910

Contacts:
First Generation Capital Inc.
Ian Ihnatowycz
President and CEO
(416) 304-9910

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

First Generation Capital Inc. Enters Into Agreement to Purchase Common Shares of Acerus Pharmaceuticals Corporation

Distribution channels: Banking, Finance & Investment Industry

EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.